synthetic biology
The firm is developing genetic reporters designed to be selectively expressed by cancer cells, producing markers detectable by imaging or other readouts.
Abcam to License Phage Library from Twist Bioscience for Antibody Discovery, Diagnostics
The deal "lays the foundations for a long-term collaboration with Abcam to drive new commercial opportunities," Twist CEO Emily Leproust said.
Ginkgo Bioworks to Go Public With $1.63B in Proceeds From SPAC Merger
The company originally announced its intention to go public through the merger with Soaring Eagle in May and will begin trading on the NYSE on Friday.
Synthetic biology and CRISPR have enabled researchers to develop wearable sensors that can detect a variety of viruses and bacteria, including SARS-CoV-2.